TEXT-EXTRACT 2 filename2.txt United States securities and exchange commission logo February 8, 2023 David Sachs CFO ImmunityBio, Inc. 3530 John Hopkins Court, San Diego California 92121 Re: ImmunityBio, Inc. Registration Statement on Form S-3 Filed February 7, 2023 File No. 333-269608 Dear David Sachs: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Arzhang Navai at 202-551-4676 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Tom Hornish, Esq.